
Issue 10, Winter 2020
General OrthoForum Policy Issues
Comment Letter on Proposed Rule for Medicare Physician Fee Schedule for CY 2021; Issuance of Final Rule
The proposed rule was published in the Federal Register on August 17 and the deadline to submit comments was October 5. To view the proposed rule, please click HERE. CMS filed the final rule with the Office of the Federal Register on December 2, and it is scheduled for official publication on December 28. To view the final rule as filed by CMS, please click HERE.
The OrthoForum submitted a comment letter to CMS on September 30. To view the comment letter, please click HERE. The letter (signed by Dr. Richard Bruch) provided comments focused on the proposed payment cuts under the physician fee schedule (PFS) for orthopaedic surgery, physical therapy, and occupational therapy. The letter also provided comments concerning the proposal to make permanent some of the telehealth flexibilities that have been authorized during the coronavirus public health emergency. These telehealth-related comments, as well as certain comments concerning the proposed payment cuts for physical therapy and occupational therapy, are discussed in the physical therapy section.
The payment cuts proposed for CY 2021 flow largely from the decision of CMS to increase payments for evaluation and management (E/M) office/outpatient visits for primary care and certain other specialties. CMS, however, believes that this increase alone is insufficient and therefore provided for an additional increase through an add-on code (GPC1X).

The OrthoForum comment letter noted that CMS did not follow the AMA RUC recommendation on RVU changes for E/M visits included in the global surgical package (which would have been beneficial), even though the agency did make the recommended changes for some global codes, such as monthly end-stage renal disease and bundled maternity care. The letter stated that this action by CMS, and the decision to provide the add-on code, may be inconsistent with the “no variation” provision of the Medicare statute because it would result in some physicians being paid less than others for E/M visits.

The payment increase for primary care and certain other specialties come at the expense of most other specialties, as their payments would be cut because of PFS budget-neutrality requirements. The comment letter stated that the proposed cut in the conversion factor is 10.6 percent, which will result in substantial payment reductions for most specialties. The letter continued, “In fact, the 2021 conversion factor may be the lowest one ever. For example, the 1994 conversion factor was higher. It was $32.9050, although that dollar amount does not indicate the true scope of what CMS is proposing, as that 1994 conversion factor would be $58.02 in today’s dollars. Therefore, adjusted for inflation, the proposed 2021 conversion factor [of $32.2605] is about 56 percent of the 1994 conversion factor. . . . Orthopaedic surgery will face an estimated cut of 5 percent, and physical therapy/occupational therapy will face an estimated cut of 9 percent. According to Table 90 [in the proposed rule], approximately 61 percent of specialties will face cuts.”
The letter forcefully criticized CMS for these proposed cuts, quoting an AMA-led letter of more than 100 medical organizations that was sent to HHS Secretary Alex Azar on July 1: “Payment reductions of this magnitude would be a major problem at any time, but to impose cuts of this magnitude during or immediately after the COVID-19 pandemic, including steep cuts to many of the specialties that have been on the front lines in efforts to treat patients in places with widespread infection, is unconscionable.” The OrthoForum letter also quoted bipartisan letters from Members of Congress to the House leadership that the proposed cuts are “reckless” and “drastic”.
The letter concluded that “it is the leadership [of CMS] who is accountable to the public for this decision and will be held responsible for the negative consequences” and that “we urge CMS to set an implementation schedule that will minimize negative effects on medical professionals and their patients.”
Turning to the final rule filed on December 2, it made no significant changes on these issues despite intense opposition to the proposed cuts from many medical organizations and a significant number of Members of Congress. The final rule kept the cuts for most providers and the increases for primary care and certain other specialties, including the add-on code (GPC1X). Table 106 in the final rule provides an updated estimate of the payment changes. The estimated cut for orthopaedic surgery is 4 percent (down from 5 percent), and the estimated cut for physical therapy and occupational therapy continues to be 9 percent. The conversion factor was increased slightly from the proposed rule—32.2605 to 32.4085—but this is still a 10.2 percent reduction from the 2020 conversion factor of 36.0896.
The final rule kept the provisions of the proposed rule that increased payment for some global codes on the basis of their E/M components but did not provide such an increase for the global surgical codes. The final rule apparently does not directly address the issue that it may be inconsistent with the Medicare statute to pay some physicians less than others for E/M visits.
The CMS Administrator, Seema Verma, reportedly stated that the cuts made by the final rule are routine, as every year there are pluses and minuses. She also indicated that the coronavirus emergency is unrelated to the payment changes, saying that the emergency is a short-term issue being addressed by the Provider Relief Fund under the CARES Act, while the payment changes made by the final rule will have a long term effect on the entire health system.

House Bills Would Address PFS Payment Cuts
Two House bills are of interest. One would offset the PFS payments cuts for two years. This bipartisan legislation is the Holding Providers Harmless From Medicare Cuts During COVID–19 Act of 2020 (H.R. 8702). The bill, introduced on October 30, 2020, by Reps. Ami Bera (D-CA) and Larry Bucshon (R-IN) (both physicians), currently has 97 cosponsors (50 Democrats and 47 Republicans). These include Rep. Fred Upton (R-MI), the former Republican chair of the Energy & Commerce Committee (2011-2017), and Rep. Diana DeGette (D-CO), the current chair of that Committee’s oversight subcommittee. The bill appears to have some momentum, as the majority of cosponsors signed on during the last half of November and more than 40 have signed on thus far in December.
The OrthoForum Advocacy Committee is coordinating with AAOS to support the bill. For 2021 and 2022, it provides supplemental payments to providers whose Medicare reimbursement would be cut under the PFS final rule, including orthopaedic surgeons, physical therapists, and occupational therapists. The supplemental payments would be the amount necessary to offset the cuts. In other words, the bill would ensure that the 2020 payment level is maintained. Certain E/M codes would be excluded. These exclusions, however, concern codes for which payment would be increased somewhat for 2021; therefore, excluding these codes, together with the supplemental payments, maintains the 2020 payment level for the relevant providers. Importantly, the exclusions also provide for a lower budget score from the Congressional Budget Office.
The excluded codes are as follows:
- The new add-on code GPC1X (which is only for primary care and certain other specialties);
- New patient codes 99202-99205, and established patient code 99211, when billed along with the new add-on code; and
- Established patient codes 99212-99215 (whether or not billed along with the new add-on code).
It must be emphasized that this bill would not have any effect on the provisions of the PFS final rule that would increase E/M payments for primary care and certain other specialties, and that would also provide the add-on code GPC1X. In other words, if the bill is enacted, those providers would still receive the same payment level as provided for under the PFS final rule. Under that rule, those providers will see significant increases above the 2020 payment level. Again, the bill is intended to assist providers whose payment level would otherwise be lower than the 2020 level.
The other bill is H.R. 8505, which would waive the PFS budget-neutrality requirements for one year. This bipartisan bill, introduced on October 2, 2020, by Reps. Michael Burgess (R-TX) and Bobby Rush (D-IL), currently has 8 cosponsors (four Democrats and four Republicans). Rep. Burgess is a physician and one of the top Republicans on the Energy & Commerce Committee. Rep. Rush is one of the top Democrats on that Committee, and he was a leader in putting together the bipartisan letters to the House leadership urging action to stop the cuts. In the weeks following the release of the PFS proposed rule, waiving the budget-neutrality requirements was a temporary solution often mentioned in discussions about how to respond to the cuts. This Burgess-Rush bill was introduced approximately a month before the Bera-Buchson bill (H.R. 8702). Of the seven cosponsors of the Burgess-Rush bill who signed on after the bill’s introduction on October 2, only one cosponsor signed on during November and none have signed on thus far in December.

The proposed rule was published in the Federal Register on August 12 and the deadline to submit comments was October 5. To view the proposed rule, please click HERE. CMS filed the final rule with the Office of the Federal Register on December 4, and it is scheduled for official publication on December 29. To view the final rule as filed by CMS, please click HERE.
The proposed rule raised a number of very important issues, which are worth discussing in some detail. The OrthoForum submitted a comment letter to CMS on October 5. To view the comment letter, please click HERE. The letter (signed by Dr. Richard Bruch) provided comments concerning the proposal to eliminate the inpatient only list, the proposal to create additional prior-authorization requirements, and the proposal to allow certain physician-owned hospitals more flexibility under the Stark Law.
The portions of the comment letter concerning the elimination of the inpatient only list are discussed below in this section (other than the portions specifically concerning ASCs), as are the portions concerning additional prior-authorization requirements. The portions of the letter concerning ASCs are discussed in the ASC section, and the portions concerning physician-owned hospitals (POHs) are discussed in the POH section.
Regarding the proposal to eliminate the inpatient only (IPO) list, the OrthoForum comment letter quoted from the proposed rule that the intention of CMS is that the physician’s “clinical knowledge and judgment, together with consideration of the beneficiary’s specific needs” should be the controlling factor. The letter stated, however, that the OrthoForum is concerned this may be aspirational to some extent, given the dynamics that exist in actual practice. Specifically, the elimination of the IPO list means that the two-midnight rule (TMR) will apply to all surgeries. The letter continued that “the TMR in actual practice means that outpatient status is the default position because hospitals want to avoid the risk of audits. Our concerns are supported by experience with the removal of total knee arthroplasty (TKA) from the IPO list. . . . CMS apparently will remove all 266 musculoskeletal procedures at once, on January 1, 2021. This mass shift from the inpatient setting to the outpatient setting will likely cause widespread confusion for physicians and patients. . . . The fundamental point is that, to the extent physicians do not in actual practice have full authority to decide whether their patients should undergo procedures on an inpatient basis, there is a potential that patients undergoing complicated procedures will experience outpatient status when there is not sufficient data to support that this is in their best interest.”
Regarding the proposal to create additional prior-authorization requirements, CMS would, effective for dates of services on or after July 1, 2021, require prior authorization for two new service categories in the outpatient setting, which are cervical fusion with disc removal, and implanted spinal neurostimulators. Rather than commenting on the merits of adding these two new prior-authorization requirements, the OrthoForum comment letter addressed the general issue of prior authorization: “Although we understand that the provision of Medicare items and services to patients must be reasonable and necessary, we also understand that patients need those items and services in a timely manner. The process of obtaining prior authorization must not cause the provision of needed care to patients to bog down, creating access problems. . . . The OrthoForum urges CMS to adopt [a] real-time electronic prior-authorization process . . . . Until this process is developed and implemented, CMS should reasonably balance the need for prior authorization with the need for patients to receive timely care and avoid adverse events.”
Turning to the final rule filed by CMS on December 4, CMS finalized its proposal to require prior authorization for cervical fusion with disc removal, and for implanted spinal neurostimulators, in the outpatient setting. The agency also acknowledged that many commenters have concerns about prior-authorization requirements in general, but the agency is not changing is approach. It first clarified that the process it is establishing specifically relates to Medicare Fee-For-Service, not Medicare Advantage. The agency continued:
[W]e believe that we have structured the Medicare Fee-For-Service prior authorization processes to effectively account for concerns associated with processing timeframes, patient care, and other administrative concerns. . . . We recognize apprehension resulting from problems with prior authorization in other settings related to burden, cost, and patient access, but as with our other Medicare Fee-For-Service prior authorization processes, we believe that the Hospital OPD prior authorization process will not have these problems. We have established timeframes for contractors to render decisions on prior authorization requests, as well as an expedited review process when the regular review timeframe could seriously jeopardize the beneficiary’s health, that we believe will enable hospitals to receive timely provisional affirmations. Additionally, we note that our prior authorization policy does not create any new documentation or administrative requirements.

With respect to the IPO list, CMS finalized its decision to eliminate it over a three-year period, and to remove all 266 musculoskeletal procedures as of January 1, 2021. The agency explained:
[We have] acknowledged the seriousness of the concerns regarding patient safety and quality of care that various stakeholders have expressed regarding removing procedures from the IPO list or eliminating the IPO list altogether. . . . However, we stated that we believe that the evolving nature of the practice of medicine, which has allowed more procedures to be performed on an outpatient basis with a shorter recovery time, in addition to physician judgment, state and local licensure requirements, accreditation requirements, hospital conditions of participation (CoPs), medical malpractice laws, and CMS quality and monitoring initiatives and programs will continue to ensure the safety of beneficiaries in both the inpatient and outpatient settings, even in the absence of the IPO list.
Regarding the applicability of the 2-midnight rule, CMS acknowledged concerns about the outpatient setting becoming the default rule, but defended its position:
CMS has repeatedly recognized that the decision regarding the most appropriate care setting for a given surgical procedure is a complex medical judgment made by the physician based on the beneficiary’s individual clinical needs and on the general coverage rules requiring that any procedure be reasonable and necessary. We continue to believe that deference should be given to physicians and medical professionals in these determinations. . . . It is a misinterpretation of CMS payment policy for providers to create policies or guidelines that establish the outpatient setting as the baseline or default site of service for a procedure based on its removal from the IPO list or the elimination of the IPO list.
The agency also declined to issue any guidance on when procedures should be performed in the inpatient setting because, under section 1801 of the Medicare statute, “CMS does not control or supervise the practice of medicine or the manner in which medical services are provided.”
The agency noted that it will continued the policy adopted in CY 2020 to provide an exemption from certain medical review activities related to the 2-midnight rule for procedures that have recently been removed from the IPO list:
Specifically, while inpatient claims for procedures that have been removed from the IPO list may be reviewed by the BFCC-QIOs for purposes of providing education to practitioners and providers on compliance with the 2-midnight rule, those claims identified as noncompliant will not be denied for such noncompliance within the first 2 calendar years of their removal from the IPO list.

As to finalizing the removal of musculoskeletal procedures from the IPO list, CMS noted the reasons it provided in the proposed rule:
[W]e proposed that musculoskeletal services would be the first group of services that would be removed from the IPO list. We stated that we believe it is appropriate to remove this group of services first for several reasons. In recent years, due to new technologies and advances in surgical care protocols, expedited rehabilitation protocols, and significant enhancements to postoperative processes we have removed TKA and THA, which are both musculoskeletal services, from the IPO list.
Prior Authorization
As noted in the discussion on the Medicare OPPS/ASCs proposed and final rules, the OrthoForum urged CMS to adopt a real-time electronic prior-authorization process, but the agency declined to make any changes, stating in the final rule filed on December 4 that the agency believes it has structured the Medicare Fee-For-Service prior authorization processes to effectively account for concerns associated with processing timeframes, patient care, and other administrative concerns.
CMS, however, released a proposed rule on December 10 to address prior authorization issues in the Medicaid and CHIP programs, and also for the federally-facilitated exchanges. Although this proposal does not concern the Medicare program, it is an important step in the right direction.
A statement issued by CMS included the following:
[The proposed rule] would improve the electronic exchange of health care data among payers, providers, and patients, and streamline processes related to prior authorization to reduce burden on providers and patients. By both increasing data flow, and reducing burden, this proposed rule would give providers more time to focus on their patients, and provide better quality care. . . .
This proposed rule ushers in a new era of quality and lower costs in health care as payors and providers will now have access to complete patient histories, reducing unnecessary care and allowing for more coordinated and seamless patient care. Each element of this proposed rule would play a key role in reducing onerous administrative burden on our frontline providers while improving patient access to health information,” said CMS Administrator Seema Verma. “Prior authorization is a necessary and important tool for payors to ensure program integrity, but there is a better way to make the process work more efficiently to ensure that care is not delayed and we are not increasing administrative costs for the whole system.” Prior authorization is not only a leading source of burden, it is also a primary source of provider burnout, and takes time away from treating patients.

As noted in previous newsletters, the OrthoForum supports a House bill (H.R.3107) that would establish an electronic prior authorization process. Although the bill concerns only MA plans, it is a good first step. The bill has 278 cosponsors (141 Democrats and 137 Republicans). In addition to establishing an electronic process, the bill would require CMS to establish a process for “real-time decisions” for items and services that are routinely approved. It would prevent plans from requiring prior authorization on any additional surgical or other invasive procedure if it is furnished during the perioperative period of an already-approved procedure. Finally, the bill would ensure accountability and transparency by requiring MA plans to report to CMS on their extent and use of prior authorizations and the rate of approvals and denials.
Additional Information
For more information on any of the topics discussed in this section, please contact the chair of the OrthoForum Advocacy Committee, Dr. Richard Bruch, at rich.bruch@gmail.com.
Physical Therapists Update
Therapy Services Virtual Seminar
The OrthoForum held a virtual therapy meeting on November 10. It included a session describing the efforts that have made during 2020 concerning Medicare telemedicine authorities and concerning the proposed payment cuts (see the discussion below on the PFS proposed rule). The virtual meeting discussed how therapists can get involved in our advocacy efforts. It was emphasized during the meeting that no experience is required to get involved—simply write Renee Duncan, the chair of the Physical Therapy Subcommittee (contact information provided at the end of this section).

Comment Letter on Proposed Rule for Medicare Physician Fee Schedule for CY 2021
As noted in the section on general policy issues, the proposed rule was published in the Federal Register on August 17 and the deadline to submit comments was October 5. To view the proposed rule, please click HERE. CMS filed the final rule with the Office of the Federal Register on December 2, and it is scheduled for official publication on December 28. To view the final rule as filed by CMS, please click HERE.
The OrthoForum submitted a comment letter to CMS on September 30. To view the comment letter, please click HERE. As noted in the section on general policy issues, the letter (signed by Dr. Richard Bruch) provided comments focused on the proposed payment cuts under the physician fee schedule (PFS) for orthopaedic surgery, physical therapy, and occupational therapy. The letter also provided comments concerning the proposal to make permanent some of the telehealth flexibilities that have been authorized during the coronavirus public health emergency. These telehealth-related comments, as well as certain comments concerning the proposed payment cuts for physical therapy and occupational therapy, are discussed in this section. The other portions of the letter are discussed in the section on general policy issues.
With respect to telemedicine, the comment letter included the following: “The OrthoForum appreciates that the Proposed Rule would make permanent some of the telehealth flexibilities that were authorized under the CARES Act and section 1135(b)(8) of the Social Security Act (SSA). We strongly support making permanent the telehealth flexibilities that were authorized for physical therapists and occupational therapists and their assistants, but we recognize that changes to the Medicare statute are likely necessary to achieve that goal.”
The letter noted that the emergency telehealth flexibilities authorize physical therapists and occupational therapists to provide telehealth services and to delegate maintenance therapy services to their assistants. The letter continued, “Once the Secretary of Health and Human Services terminates the declaration of a coronavirus public health emergency, however, the scope of telehealth services in the Medicare program will once again be governed by SSA section 1834(m). Subsection (m) authorizes telehealth services for physicians and ‘practitioners’, which is defined in a manner that excludes physical therapists and occupational therapists and their assistants.”
Given the need for legislation, the letter concluded, “The OrthoForum supports legislation that would amend section 1834(m) to establish permanent authority for physical therapists and occupational therapists and their assistants to provide telehealth services. This authority would be truly permanent in that it would not be conditioned on the existence of a national emergency or on CMS granting a waiver. The legislation would specify particular Medicare billing codes that apply to physical therapy and occupational therapy and provide that, for those codes, telehealth geographic limitations would not apply.”
Although not expressly mentioned in the comment letter, a bill in Congress supported by the OrthoForum would provide the scope of telemedicine authority described in the letter. This legislation is the Outpatient Therapy Modernization and Stabilization Act (H.R. 7154). This bipartisan House bill, introduced on June 11, 2020, by Reps. Brendan Boyle (D-PA) and Vern Buchanan (R-FL), currently has 14 cosponsors (13 Democrats and 1 Republican). These include Rep. Carolyn Maloney (D-NY), the chair of the House Oversight Committee.
Turning to the proposed PFS payment rates for CY 2021, physical therapy and occupational therapy would face an estimated 9 percent payment cut due to the PFS budget-neutrality requirements. This cut would be made to help offset the increase in payments that CMS would make for evaluation and management (E/M) office/outpatient visits for primary care and certain other specialties, as well as the increase in payments for such visits that would be provided by an additional add-on code (GPC1X) created by CMS. (Orthopaedic surgery would have an estimated 5 percent cut. Overall, approximately 61 percent of specialties would face cuts.)
The comment letter stated that the OrthoForum is “concerned about the effects of the proposed cuts on physical therapists and occupational therapists and their assistants, who are integral to orthopaedics. These health professionals are widely utilized within the U.S. healthcare system to address a variety of conditions prevalent in the Medicare patient population, such as post-operative surgical conditions, musculoskeletal conditions, and arthritis, among others. Many OrthoForum physician group practices (PGPs) participate in programs with incentives to provide value-based care, rather than using a procedure-by-procedure, fee-for-service approach. Physical therapists and occupational therapists and their assistants have a central role in value-based care. For example, OrthoForum PGPs know that these therapists, together with patient navigators, can assist physicians in improving outcomes for hip and knee replacements and in achieving saving of approximately $1,000 per episode. Physical therapists and occupational therapists and their assistants work with physicians to optimize patients for surgery (managing weight, blood pressure, nutrition, and other health factors); reducing or eliminating the need for a stay at a rehabilitation facility; and facilitating a more rapid recovery from the surgery.”

The letter forcefully criticized CMS for the broad-based cuts to specialties that the proposed rule would make, quoting an AMA-led letter of more than 100 medical organizations stating that the cuts would be “unconscionable.” The letter also quoted bipartisan letters from Members of Congress to the House leadership that the proposed cuts are “reckless” and “drastic”. The letter concluded that “it is the leadership [of CMS] who is accountable to the public for this decision and will be held responsible for the negative consequences” and that “we urge CMS to set an implementation schedule that will minimize negative effects on medical professionals and their patients.”
Turning to the final rule filed on December 2, it made no significant changes on these payment issues despite intense opposition to the proposed cuts from many medical organizations and a significant number of Members of Congress. The final rule kept the cuts for most providers and the increases for primary care and certain other specialties, including the add-on code (GPC1X). Table 106 in the final rule provides an updated estimate of the payment changes, and it shows that the estimated cut for physical therapy and occupational therapy continues to be 9 percent. The conversion factor was increased slightly from 32.2605 to 32.4085, but this is still a 10.2 percent reduction from the 2020 conversion factor of 36.0896.
With respect to making the new emergency telemedicine flexibilities permanent, the final rule appears to analyze the situation in the same way as the OrthoForum comment letter. Specifically, the final rule states that (1) at the conclusion of the coronavirus public health emergency, the authority of the agency will once again be limited by SSA section 1834(m), and (2) physical therapists and occupational therapists are not “practitioners” within the meaning of that statutory provision; therefore, CMS does not have the authority to add their services to the Medicare telehealth services list.
The final rule, however, does make a change related to the coronavirus emergency that is beneficial. Rather than the telehealth flexibilities for physical therapists and occupational therapists expiring immediately upon the conclusion of the emergency, the flexibilities will continue until the end of the year in which the emergency expires. The final rule accomplishes this policy by creating a new telemedicine “Category 3” for telehealth services that were first allowed during the emergency and for which CMS believes there is likely to be clinical benefit, but for which there is not yet sufficient evidence to include them in Category 1 or 2. These latter two categories concern telehealth services that the public has requested be added to the Medicare telehealth services list (TSL). Category 1 is for requests to add telehealth services that are similar to services already on the TSL and are similar in terms of the telecommunications systems that are used to deliver the services. Category 2 is for requests to add telehealth services that are not similar to those on the TSL, and therefore CMS will consider evidence presented to demonstrate that the requested services provide a clinical benefit. (The final rule provides examples of clinical benefit.) CMS considers these requests and then makes a decision through notice-and-comment rulemaking on whether to add them to the TSL.
The final rule includes a Table 16 of services being added to the TSL. This table includes physical therapy and occupational therapy, although the addition is temporary because they are in Category 3. The specific codes are CPT 97161- 97168; CPT 97110, 97112, 97116, 97535, 97750, 97755, 97760, 97761, 92521- 92524, and 92507.
In addition, the final rule states that CMS is finalizing its interim policy (from the May 8th COVID-19 interim final rule) to allow physical and occupational therapists to delegate maintenance therapy services to therapy assistants as clinically appropriate through the end of the coronavirus public health emergency (but not through the end of the year in which the emergency concludes).

House Bills Would Address PFS Payment Cuts
Details on these two bills (H.R. 8702 and H.R. 8505) are provided in the section on general policy issues. H.R. 8702 currently has 97 cosponsors (50 Democrats and 49 Republicans). The OrthoForum Advocacy Committee is coordinating with AAOS to support the bill. For 2021 and 2022, it provides supplemental payments to providers whose Medicare reimbursement would be cut under the PFS final rule, including physical therapists, occupational therapists, and orthopaedic surgeons. The supplemental payments would be the amount necessary to offset the cuts. In other words, the bill would ensure that the 2020 payment level is maintained. Importantly, a very similar bill was introduced in the Senate on December 10 (S. 5007).
The other bill, H.R. 8505, would waive the PFS budget-neutrality requirements for one year. It currently has 8 cosponsors (four Democrats and four Republicans).
Physical Therapy Subcommittee
For more information on PT issues, or to join the OrthoForum Advocacy Committee Physical Therapy Subcommittee, please contact Renee Duncan at: renee.duncan@orthotennessee.com.
CMS, CMMI and BPCI-A Updates
Overall Direction of CMMI
In a statement on October 13 to a virtual meeting of the Healthcare Payment Learning and Action Network, the Administrator of the Centers for Medicare & Medicaid Services (CMS), Seema Verma, raised concerns about the demonstration models created by the Center for Medicare and Medicaid Innovation (CMMI). She called for a “course correction” on how savings benchmarks are set, stating that “[t]he bottom line is CMMI models are losing money, generating large losses, and a weak return on investment for taxpayers.” Verma noted that only five of the 54 CMMI payment models have shown statistically significant savings, and that the financial benchmarks set to encourage participation in the CMMI models have been “too generous with considerable local variation, which creates significant selection bias.” She also used the example of ACOs to make the point that participants need “skin in the game” in order to better perform.
Speaking at the same event, CMMI Director Brad Smith said the Center will test benchmarks before using them in future models to ensure they are more accurate. Smith said, “What we have seen historically is without that kind of rigorous testing, the benchmarks don’t always accurately represent the cost and that results in the models either losing money or us having to change the benchmarks in the middle of a model.”

2021 Changes to BPCI-A Model
On September 10, CMMI announced changes in the pricing methodology to the existing Bundled Payments for Care Improvement Advanced (BPCI-A) model beginning in Model Year 4 (MY4), which begins on January 1, 2021. With respect to the outcomes of reconciliations for Model Years 1 and 2 and a prospective model trend in BPCI-A, CMMI Director Brad Smith stated that close to $2 billion in losses is projected for the 10 performance periods over the lifetime of the model, and that this projected loss is the basis for the MY4 changes. Smith has urged CMS to make changes aimed at making BPCI-A break even by the end of its duration.
Changes to the BPCI-A pricing methodology for MY4 include the following:
- Utilization of a realized trend adjustment to the peer group trend (PGT): Target prices use peer groups to benchmark providers against other providers with similar hospital-level characteristics. CMS will adjust final Target Prices at Reconciliation for peer group trends found in Performance Period Clinical Episodes spending. The agency will cap the difference between the realized PGT factor from the preliminary PGT factor at 10 percent of the preliminary trend.
- Removal of the Physician Group Practice (PGP) offset: CMS will remove the PGP Offset used in PGP Target Prices Construction. Currently, the PGP Offset is a component of the Target Price, and measures a PGP’s efficiency relative to a specific hospital where the PGP initiates Clinical Episodes. This means that there’s a separate PGP Offset for every hospital at which a PGP’s Clinical Episodes are initiated. The PGP’s efficiency is calculated as the mean of the ratio of observed to expected spending across all of the EI’s baseline Clinical Episodes in the Clinical Episode category.
- Modified Clinical Episode Overlap Methodology: Clinical Episodes will not overlap in either the baseline or Performance Period and will be attributed without regard to participation in both periods. Currently, Clinical Episodes in the baseline period are allowed to overlap and are attributed to both non-Participants and Participants. Such overlap is not permitted during the Performance Period.
- Major Joint Replacement of the Lower Extremity (MJRLE) Risk Adjustment: CMS is making changes because the current risk adjustment model that sets the MJRLE Target Prices systematically overpredicts spending on knee procedures and underpredicts spending on hip procedures. To improve the accuracy of payment for MJRLE Clinical Episodes, the agency therefore will add the following procedure flags to the MY4 risk adjustment model for MJRLE: (1) Partial Knee Arthroplasty, (2) Total Knee Arthroplasty, (3) Partial Hip Arthroplasty, (4) Total Hip Arthroplasty and Hip Resurfacing, and (5) Ankle and Reattachments and Others. CMS will also use combinations of flags, where applicable.
- Clinical Episode Service Line Groups (CESLGs): This is a particularly important change. Currently, Participants choose to participate in and are held accountable for any number of Clinical Episode categories that are indicated in their Participant Profiles. In MY4, Participants will be required to select Clinical Episode Service Line Groups (CESLGs), instead of one or more Clinical Episode categories. Participants will not be conditionally required to participate in Clinical Episodes categories, within any CESLG, that do not meet the minimum volume threshold during the baseline period. To be accountable for a Clinical Episode Category within a CESLG, the Episode Initiators (EIs) who are acute care hospitals must trigger at least one Clinical Episode in the Performance Period and meet the minimum volume requirement in the baseline period. The EIs who are PGPs must trigger at least one Clinical Episode in the Performance Period at an acute care hospital that meets the minimum volume requirement in the baseline period.
As noted, the CESLG change is particularly important. There are eight CESLGs. The Orthopaedics CESLG includes all of the following:
- Double Joint Replacement of the Lower Extremity;
- Fractures of the Femur and Hip or Pelvis;
- Hip and Femur Procedures Except Major Joint;
- Lower Extremity/Humerus Procedure Except Hip, Foot, Femur;
- Major Joint Replacement of the Lower Extremity (Inpatient and Outpatient); and
- Major Joint Replacement of the Upper Extremity
For more information on these MY4 changes, please click HERE
Future of Bundled Payment Models
The message from CMMI Director Brad Smith on September 10 included the following:
The Innovation Center remains strongly committed to moving forward with testing bundled payments. As a next step, we plan to accelerate our work on a new bundled payment model that we anticipate launching as a mandatory model after BPCI Advanced. By being mandatory, we are optimistic this future model will mitigate many of the selection effects we have seen in BPCI and BPCI Advanced.
It therefore appears that, in deciding whether to remain in the BPCI-A program for MY4, participants should take into account the possibility that down the road they may find themselves having to participate in a mandatory orthopaedics bundled payment program.
CMS Interim Final Rule; Extension of CJR Model End Date
On October 28, CMS released its fourth COVID-19 Interim Final Rule with comment period (IFC-4). Among other provisions, it includes provisions to:
- Set price transparency requirements for providers and COVID-19 diagnostics tests;
- Remove administrative barriers to eliminate potential delays in vaccine access; and
- Extend the Comprehensive Care for Joint Replacement (CJR) model end date.
Specifically, as to the CJR model, CMS would extend Performance Year (PY) 5 of the model from March 31, 2021, through September 30, 2021, an additional six months. To accommodate the extension to PY5, CMS will perform two reconciliations to divide PY5 —one for the first 12 months of PY 5 and one for the remaining nine months of PY 5. This rule also ends the current COVID-19 extreme and uncontrollable circumstances policy on March 31, 2021 or the end of the coronavirus public health emergency, whichever occurs first. After that, to address ongoing effects of the pandemic, actual episode payments will be capped at the quality adjusted target price for any episode with actual episode payments that include a claim with a COVID-19 diagnosis code. Lastly, to ensure that the model continues to include the same inpatient Lower Extremity Joint Replacement (LEJR) procedures, despite the adoption of new MS-DRGs 521 and 522 to describe those procedures, CMS makes a technical change, as of October 1, 2020, to include these new DRGs in the model.
For more information on this CMS COVID-19 Interim Final Rule, please click HERE.
CMMI Subcommittee
The Subcommittee is currently seeking a new chair. In the interim, for more information on CMMI and BPCI-A issues, or to join the OrthoForum Advocacy Committee CMMI Subcommittee, please contact the chair of the Advocacy Committee, Dr. Richard Bruch, rich.bruch@gmail.com.
Stark Law Update
Issuance of Stark Law Final Rule
As reported in previous newsletters, the Department of Health and Human Services (HHS) issued two proposed rules on October 17, 2019, one concerning the Stark Law, which was issued by HHS’s Centers for Medicare & Medicaid Services (CMS), and one concerning the Anti-Kickback Statute (AKS), which was issued by the HHS Office of Inspector General (OIG). Both rules concern exceptions for value-based arrangements (VBAs).
In December 2019, the OrthoForum submitted a comment letter to CMS on the Stark proposed rule, emphasizing the need for simplicity regarding the VBA exceptions for physician group practices; the need for CMS to provide guidance and advisory opinions to PGPs on fair market value issues; and the need to harmonize the VBA exceptions under the Stark Law proposed rule with the VBA exceptions under the AKS proposed rule. Also in December 2019, the OrthoForum sent an AKS-focused letter to the HHS OIG emphasizing the need to harmonize the two proposals. To view the comment letter on the Stark proposed rule, please click HERE. To view the comment letter on the AKS proposed rule, please click HERE.
On August 26, 2020, CMS announced that it was delaying publication of the Stark final rule until August 2021. The agency said it needed the additional time because it was “still working through the complexities of the issues raised by comments received on the proposed rule.” It was not clear whether the AKS final rule was also being delayed, as it is under the jurisdiction of the HHS OIG, not CMS.
Notwithstanding the August announcement by CMS, the Stark final rule and the AKS final rule were filed with the Office of the Federal Register on November 20, 2020. The Stark final rule was officially published on December 2, 2020, and the AKS final rule was officially published on November 30, 2020. To view the Stark final rule, please click HERE. To view the AKS final rule, please click HERE.
Note that the Stark final rule only concerns exceptions for compensation arrangements. It does not concern exceptions for ownership or investment interests (and therefore does not concern the Stark restrictions on physician-owned hospitals).
In the Stark final rule, CMS acknowledged the need to coordinate the Stark regulations with the AKS regulations. The agency indicated that it made efforts in this regard, but that complete alignment between the two regulatory programs is not possible:
Several commenters encouraged CMS and OIG to work together to more closely align their final rules. The commenters expressed concern that notable differences between the two rules, if finalized as proposed, would create a dual regulatory environment, where a value-based arrangement could meet the requirements for protection under one law but not the other, which could hinder the transition to a value-based health care delivery and payment system. These commenters expressed concern with administrative burden and compliance concerns in the event that the OIG and CMS final rules are not aligned. One commenter viewed the exceptions to the physician self-referral harbors to the anti-kickback statute are not revised to mirror the exceptions noting that participants are likely to abide by the more stringent requirements included in the safe harbors.
We share the commenters’ concerns about dual regulatory schemes and the challenges for stakeholders in ensuring compliance with both. We have worked closely with OIG to ensure consistency between our respective rules to reduce administrative burden on the regulated industry. . . . However, because of the fundamental differences in the statutory structure, operation, and penalties between the physician self-referral law and the anti-kickback statute, complete alignment between the exceptions to the physician self-referral law and safe harbors to the anti-kickback statute is not feasible.
Importantly, CMS acknowledged the need for guidance:
This final rule also provides critically necessary guidance for physicians and health care providers and suppliers whose financial relationships are governed by the physician self-referral statute and regulations. . . . [It] includes clarifying provisions and guidance intended to reduce unnecessary regulatory burden on physicians and other health care providers and suppliers, while reinforcing the physician self-referral law’s goal of protecting against program and patient abuse.
As to other issues, the OrthoForum comment letter discussed that, when a physician group practice (PGP) participates in a CMS-sponsored alternative payment model (APM), it can be logistically burdensome for the PGP to segregate its patients who are part of the APM from its patients who are not. Doing so is required because a Stark waiver applies only with respect to patients in the APM. The letter noted that PGPs want to be able to treat all patients with similar medical conditions the same. It seems that the proposed rule would allow this, since the patients who are not part of the APM could be part of a parallel value-based arrangement (VBA).
In creating this parallel VBA, however, the PGP would have to make an independent judgment as to whether its VBA meets the requirements of one of the new Stark VBA exceptions. The comment letter sought a mechanism through which CMS would confirm to the PGP that the waiver granted for the APM is a basis for the PGP to presume that similarly-situated patients not in the model are covered by one of the new VBA exceptions.

The final rule, however, did not specifically respond to this request from the OrthoForum. Some comment letters requested that the final rule specify that specific CMS-sponsored APMs are VBAs, but the agency declined to do so. It appears that the agency is reluctant to discuss in detail the relationship between these APM waivers and VBA exceptions. CMS stated that an APM concerns the relationship between a payor and a physician, whereas a VBA concerns the relationship between a physician and an entity to which the physician makes referrals. The agency did finalize its position that the availability of the new VBA exceptions will eliminate the need for any additional waivers for CMS-sponsored APMs.
The OrthoForum comment letter noted that it is helpful that, under current CMS regulations, PGPs can seek advisory opinions on whether specific situations comply with the Stark Law; however, these regulations state that CMS will not issue advisory opinions on issues concerning fair market value (FMV). The letter noted that the proposed rule is taking an innovative approach on FMV matters—in particular, the “volume or value of referrals” matter. Therefore, advisory opinions from CMS will be a critical factor in giving physicians confidence to use the new VBA exceptions as they relate to FMV. The letter requested that CMS modify its advisory-committee regulation to reflect the final rule in this regard. The agency, however, did not discuss this issue in its final rule and did not amend the advisory-committee regulation.
The comment letter recommended some technical changes to one of the proposed rule’s revisions to the Stark Law regulations. This revision would create an exception for the “volume or value of referrals” restriction in certain circumstances in which a group practice is involved. This proposed VBA exception relates to whether the definition of “group practice” is met. The letter made the point that the way the group-practice VBA exception was drafted—specifically, its structure—was not parallel to the structure of two other related exceptions that were being created, and therefore could lead to problems in the way the group-practice VBA exception is interpreted. The final rule states, “The commenter is correct about the structure of the three provisions . . . We have revised the final regulation accordingly.”
This section of the newsletter has discussed specific comments the OrthoForum made in its letter responding to the Stark proposed rule, and it has discussed the responses of CMS to those comments. The issues discussed in the comment letter are only a subset of the many Stark issues that OrthoForum PGPs will face going forward. For example, the final rule creates, for the first time, a definition of the “volume or value” standard and the “other business generated” standard, and these definitions, at least to some extent, supersede previous guidance. Rather than following the past approach of deeming certain situations as not taking volume or value into account, or not taking other business generated into account, the regulations now specify the particular situations in which volume or value, or other business generated, are considered to have been taken into account. All situations not within the specified situations are considered permissible.
CMS says it is trying to create a “bright line.” The agency states that “only when the mathematical formula used to calculate the amount of the compensation includes referrals or other business generated as a variable, and the amount of the compensation correlates with the number or value of the physician’s referrals to or the physician’s generation of other business for the entity, is the compensation considered to take into account the volume or value of referrals or take into account the volume or value of other business generated.”
Nevertheless, with respect to group practices and special rules for profit shares and productivity bonuses, the final rule states that, per the new group-practice VBA, “a group practice may distribute directly to a physician in the group the profits from designated health services furnished by the group that are derived from the physician’s participation in a value-based enterprise, including profits from designated health services referred by the physician, and such remuneration will be deemed not to be based on (or take into account) the volume or value of the physician’s referrals.”
CMS continued:
Physician #1 could receive a profit distribution that considers his or her referrals to the group that are directly attributable to his or her participation in the value-based enterprise (and its corresponding participation in the model), and Physician #2 could receive a profit distribution that considers his or her referrals to the group that are directly attributable to his or her participation in the value-based enterprise (and its corresponding participation in the model). Neither distribution would jeopardize the group’s ability to qualify as a “group practice . . .”
Discussing the Stark final rule in greater detail is beyond the scope of this particular newsletter, although the Advocacy Committee will work to learn more and inform OrthoForum members. All PGPs will now begin a long learning process concerning the new VBA exceptions, as well as other changes made by this final rule.

Stark Law Subcommittee
For more information on Stark Law issues, or to join the OrthoForum Advocacy Committee Stark Law Subcommittee, please contact Dr. Chip Hummer at: chummer3@premierortho.com.
Ambulatory Surgery Center Update

ASC Virtual Seminar
This virtual seminar took place in November. The three sessions—held on the 4th, the 11th, and the 18th—overall covered (1) Quality Data Collection–the Whys and Hows; (2) Lessons Learned Through COVID-19 and Infection Control; (3) AAAHC Total Joint Certification; (4) Spine and Joint Panel Discussion; and (5) Increased Medicare Volumes in the ASC.
The sessions were well attended. Among the topics discussed was the increase in the number of procedures on the Medicare covered procedures list (CPL) due to TKA being added to the CPL, the proposed addition of THA to the CPL, and the proposed elimination of the inpatient only (IPO) list. Another topic was the need to keep the site-of-service decision with the surgeon. In addition, there was discussion of the risk that high-cost cases could create an access issue for patients if reimbursement levels result in an unsustainable situation for ASCs. There also was discussion of advocacy efforts at the state and federal levels to continue to promote the high quality of care at ASCs while acknowledging that the number of higher-acuity cases is increasing.
Comment Letter on OPPS/ASCs Proposed Rule; Issuance of Final Rule
As noted in the section on general policy issues, the proposed rule was published in the Federal Register on August 12 and the deadline to submit comments was October 5, 2020. To view the proposed rule, please click HERE. CMS filed the final rule with the Office of the Federal Register on December 4, and it is scheduled for official publication on December 29. To view the final rule as filed by CMS, please click HERE.
The OrthoForum submitted a comment letter to CMS on October 5 in response to the proposed rule. To see the letter, please click HERE. The letter (signed by Dr. Richard Bruch) provided comments concerning the proposal to eliminate the IPO list, the proposal to create additional prior-authorization requirements, and the proposal to allow certain physician-owned hospitals more flexibility under the Stark Law. Only ASC-specific issues are discussed in this section. For other issues concerning the proposed rule, see the section on general policy issues and the section on physician-owned hospitals.
The proposed rule recognized that the elimination of the IPO list raises the issue of which procedures will be added to the ASC CPL. The OrthoForum letter supported a proposal from CMS that the agency would solicit CPL nominations from medical specialty societies and other stakeholders; would encourage the consideration of guidance from the agency establishing parameters; would provide for the nomination process to be conducted through annual notice-and-comment rulemaking; and would establish this nomination process in the OPPS/ASC 2021 final rule for decisions that would be finalized in the OPPS/ASC 2022 final rule.

The comment letter also addressed the issue that CMS appears to believe that the ASC system is subject to budget-neutrality requirements. The letter stated, “If in fact the ASC system has a budget-neutrality limitation, then the elimination of the IPO list presents a problem. Over time, more and more procedures will be added to the ASC CPL. This means that, with a finite budget ‘pie’, each procedure will over time receive a smaller and smaller slice of the pie, since the size of the overall pie cannot be increased regardless of how many individual slices (procedures) exist. Therefore, payment levels for specific procedures will ultimately become unsustainable for ASCs, which in turn will create access barriers for patients.”
Finally, with respect to the elimination of the IPO list, the comment letter stated that this “will dramatically increase the migration of procedures from the HOPD setting to the ASC setting. This highlights an issue that has been developing over the years. The OrthoForum believes there should be site neutrality between ASCs and HOPDs in terms of Medicare payments [although] HOPDs should receive a higher rate when performing outpatient procedures that are not on the ASC CPL. . . . The optimal solution is for the current HOPD conversion factor and the current ASC conversion factor to meet somewhere in the middle (subject to the risk adjustment for HOPDs described above).”
Turning to the final rule filed by CMS on December 4, the agency used the term “site neutrality” to describe the result of adding more procedures to ASC CPL, not to describe comparative levels of Medicare payments, but the agency did acknowledge that “[m]any commenters believe that CMS needs to reduce the disparity in payments between ASCs and HOPDs.” The agency continued, “Many of the same commenters support the discontinuation of the ASC weight scaler . . . [and] do not believe it is necessary to calculate a weight scaler under the ASC payment system.” CMS, however, maintained its position of requiring budget neutrality, although it appeared to acknowledge a statement in the OrthoForum comment letter: “One commenter . . . suggested the while expansion of the ASC Covered Procedures List would allow more procedures to be performed in the ASC, these additional procedures will not be performed in the ASC if ASC payment rates are lowered to unsustainable levels over time.”
With respect to the elimination of the IPO list and the issue of how to decide which procedures will be added to the ASC CPL, the final rule noted that the majority of commenters supported the proposal to establish a nomination process (described above). CMS, however, did not finalize that proposal and instead created an approach that is a hybrid of the two alternatives presented in the proposed rule. Both alternatives concern the regulations at 42 CFR 416.166, which establish general criteria for procedures to be included in the ASC CPL, and also criteria for excluding procedures from it.
The general inclusion criteria are that the procedure is separately paid under the OPPS, is not expected to pose a significant safety risk to a patient when performed in an ASC, and for which standard medical practice dictates that the patient would not typically be expected to require active medical monitoring and care at midnight following the procedure. Examples of exclusion criteria include that the procedure requires major or prolonged invasion of body cavities, or that the procedure directly involves major blood vessels.
The final rule will alter the way in which some of the current inclusion and exclusion criteria apply. Rather than being requirements, these criteria will become factors to be considered by physicians in making site-of-service determinations for their patients. As to inclusion criteria, physicians, not CMS, will consider whether a surgical procedure is not expected to pose a significant safety risk for specific beneficiaries and is one for which standard medical practice dictates the beneficiary would not typically be expected to require active medical monitoring and care at midnight following the procedure. As to exclusion criteria, physicians, not CMS, will consider criteria such as whether the procedure requires major or prolonged invasion of body cavities, or the procedure directly involves major blood vessels. The final rule states, “Physicians are not required to maintain new documentation of their determination that procedures meet the revised CPL regulatory criteria, beyond what they are already required by Medicare.”
This approach means that, for the inclusion and exclusion criteria noted above, CMS will defer to the judgment of the physician. In other words, the agency will not second-guess the decision of the physician.

CMS, however, creates four additional criteria that the agency itself will apply and make the decisions as to whether the criteria are met. Specifically, CMS is requiring that, in order to add a procedure the ASC CPL, the procedure be: (1) separately paid under the OPPS; (2) not designated as requiring inpatient care under § 419.22(n) as of December 31, 2020 (the IPO list); (3) not only able to be reported using a CPT unlisted surgical procedure code; or (4) not otherwise excluded under § 411.15 (e.g., routine physical checkups, eye examinations, and hearing aids).
The IPO-related restriction on adding procedures to the ASC CPL is tied to the elimination of the IPO list over three years. By making decisions over the three years as to which procedures remain on the IPO list, the agency is controlling which procedures potentially can be added to the ASC CPL.
CMS will on its own add procedures to the ASC CPL when it determines that the procedures meet the four requirements noted above, but the agency is also establishing a process for the public to suggest additions. Rather than using a formal nomination process for the public to use, CMS is establishing a notification process in which any person may notify the agency that the person believes a procedure meets the four requirements. The agency will then determine whether the four requirements are met and if so will add the procedure. CMS is using this notification procedure because it expects that industry may become aware of procedures that the agency may not know about.
The final rule will (as proposed) add 11 codes to the ASC-CPL, including total hip arthroplasty (THA). CMS notes that these additions are being made under the current requirements, not the new ones that take effect on January 1, 2021. In addition, CMS is, under the new requirements, adding 267 surgery and surgery-like codes, effective on that date.
Turning to other provisions of the final rule, CMS will continue to use the hospital market basket to update the conversion factor for CY 2021 through CY 2023. For CY 2021, the update for ASCs meeting the quality reporting requirements is 2.4 percent (down from 2.6 percent in the proposed rule), which results in a conversion factor of $48.952. For ASCs not meeting those requirements, the update is 0.4 percent (down from 0.6 percent in the proposed rule), which results in a conversion factor of $47.996. Both of these conversion factors are about 59% of the parallel amounts for HOPDs.
As to making updates to the conversion factor, CMS noted that several commenters provided input on collecting cost data from ASCs. The agency stated that it “will continue to assess the feasibility of collaborating with stakeholders to collect ASC cost data in a minimally burdensome manner”. Importantly, the agency continued that it potentially could “propose a plan to collect such information during the 5-year period in which CMS has updated the ASC payment methodology to rely upon the hospital market basket as the update factor”.
ASC Subcommittee
For more information on ASC issues, or to join the OrthoForum Advocacy Committee ASC Subcommittee, please contact Teresa Copeland at:
teresa.copeland@orthotennessee.com
Balance Billing Update
Final Efforts by Congress in 2020
Congress clearly wants to reduce out-of-pockets expenses for patients that may result from balance billing for items and services for out-of-network care. The controversy concerning legislation to address this issue results from the differences among various proposals in determining the payment amounts for such care.
All of the major proposals in Congress for addressing the balance-billing issue would save money; therefore, the House and Senate have indicated their interest in including balance-billing provisions in a large package for which offsets (“pay-fors”) for provisions increasing spending would be needed.
It’s possible that balance-billing provisions could be included in the next COVID-19 stimulus package, although negotiations between the House and Senate and the White House to reach a deal on such a package have, without success, been taking place on and off since the end of June. Even now, after the November elections, they apparently are far apart in their positions as to the size and scope of the package.

Another possibility is that balance-billing provisions could be included in a large package to provide additional funding for the federal government for fiscal year 2021, which began on October 1. A bill was enacted on that date to provide funding through December 11. Given this deadline (which on December 11 was extended through December 18), it appears that Congress will in December pass a large package that will include the content of the 12 regular appropriations bills (each concerning particular agencies and programs) that annually fund the government. Although negotiations to pass a separate COVID-19 stimulus bill have taken place unsuccessfully for months, it now appears that some COVID-related provisions will be included in the large funding package currently being developed. Congress may want some of these COVID-related provisions to have pay-fors. In addition, other provisions may be included for which there would be pay-fors, such as healthcare “extenders” (e.g., supplemental funds for community health centers).
The balance-billing proposal likely of most interest to OrthoForum members is the one presented by the House Ways and Means Committee. Unlike the other major proposals, it does not set the in-network median payment as the benchmark. If a plan and a provider are unable to reach agreement informally, either party could initiate a 30-day negotiation process. If the matter is not resolved within that period, either party could initiate a mediation process with an independent third party. There would be no minimum dollar threshold to enter the mediation process. Although the mediator would consider the relevant median contracted rate, the mediator would also consider the offers of both parties and all supporting information provided by the parties.
In contrast, the Senate Health, Education, Labor, and Pensions (HELP) Committee, the House Energy and Commerce Committee, and the House Education and Labor Committee all support an approach that allows mediation but uses the in-network median payment as the benchmark.
The Department of Health and Human Services (HHS) supports efforts in Congress to address balance billing, but has not supported a particular approach. HHS, however, administratively addressed this issue with respect to payments received from the Provider Relief Fund established under the CARES (enacted in March). The terms and conditions for such payments state that “for all care for presumptive or actual case of COVID-19, Recipient certifies that it will not seek to collect from the patient out-of-pocket expenses in an amount greater than what the patient would have otherwise been required to pay if the care had been provided by an in-network Recipient.”
A growing coalition of medical organizations is urging Congress not to use the in-network median payment as the benchmark because it ties physician payments to an insurer-calculated rate. In analyzing the Energy and Commerce approach, the Congressional Budget Office (CBO) estimated that payments for both in-network care and out-of-network care would converge around the in-network median payment. CBO used an example in which the in-network payment for emergency room (ER) physicians averages 260 percent of the Medicare rate, with some ER physicians paid at a much higher rate and some paid at a lower rate. Assume the median rate is 225 percent of the Medicare rate; therefore, the average rate is significantly higher than the median rate. The insurer would pay out-of-network ER physicians at that median rate. For in-network ER physicians, CBO expected that, for all of them who have been paid more than the median rate, insurers would reduce their payments, even if some of them refused the lower rate and dropped out of the network. Meanwhile, in-network ER physicians earning less than 225 percent of the Medicare rate would insist on increases or would drop out of the network. Overall in this example, the in-network payment would fall from an average of 260 percent of the Medicare rate to an average of 225 percent of that rate, a decrease of 35 percent. (CBO noted that actual median in-network rates vary markedly across the nation, as do the differences between the average and median rates.)

Dr. Doug Lundy, the Chair of our Balance Billing Subcommittee, has noted that physicians have obvious objections to this in-network median methodology, and that adopting it would add to the stress of physician practices threatened by the COVID-19 pandemic.
The Advocacy Committee is coordinating with AAOS in support of the Ways and Means approach. It appears that approach has quietly been gaining momentum in the House, although it is difficult to predict what will happen during the “horse trading” that likely is taking place in negotiating the final funding package for 2021. The Advocacy Committee will continue its effort and will reassess once the new Congress begins in January (the 117th Congress).
As of December 10, Ways and Means still has not reached agreement with the other three committees, even though House Speaker Nancy Pelosi has been pushing for a deal. The Chair of the Ways and Means Committee, Rep. Richard Neal (D-MA), reportedly is suggesting that Congress wait until next year to take action on the balance-billing issue.
Balance Billing Subcommittee
For more information on balance billing issues, or to join the OrthoForum Advocacy Committee Balance Billing Subcommittee, please contact Dr. Doug Lundy at: LundyDW@resurgens.com.
Physician-Owned Hospital (POH) Update
Comment Letter on OPPS/ASCs Proposed Rule; Issuance of Final Rule
As noted in the section on general policy issues, the proposed rule was published in the Federal Register on August 12 and the deadline to submit comments was October 5, 2020. To view the proposed rule, please click HERE. CMS filed the final rule with the Office of the Federal Register on December 4, and it is scheduled for official publication on December 29. To view the final rule as filed by CMS, please click HERE.
The OrthoForum submitted a comment letter to CMS on October 5 in response to the proposed rule. To see the letter, please click HERE. The letter (signed by Dr. Richard Bruch) provided comments concerning the proposal to eliminate the IPO list, the proposal to create additional prior-authorization requirements, and the proposal to allow certain physician-owned hospitals (POHs) more flexibility under the Stark Law. Only POH-specific issues are discussed in this section. For other issues concerning the proposed rule, see the section on general policy issues and the ASC section.
The OrthoForum comment letter stated that we appreciate that the proposed rule would make changes regarding the applicability of the Stark Law to POHs. With respect to the Stark POH cap on the number of additional operating rooms, procedure rooms, and beds above the POH’s baseline number, this proposal included provisions to lift restrictions for POHs qualifying as “high Medicaid facilities”, meaning POHs that serve more Medicaid inpatients than other hospitals in the counties in which they are located. The letter stated that the OrthoForum supports this proposal.
The Comment Letter Focused on the Broader Issues
The decision in 2010 to impose the Stark POH restrictions should be reconsidered, given the changes in the healthcare system since then and also the excellent track record of POHs since then. CMS now has great experience with alternative payment models, and the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) created additional incentives for the use of such models. Through these models, Congress and CMS are moving the healthcare system away from the procedure-based, fee-for-service (FFS) approach and toward a value-based approach. Thus, the FFS-related concerns that motivated some people to advocate for the creation of the POH restrictions are no longer generally applicable. In fact, POHs consistently rank high on quality measures and provide some of the best care at the lowest cost. They have demonstrated their value through their performance on quality measures such as readmission rates, length of stay, case mix index, infection rates, and the Hospital Consumer Assessment of Healthcare Providers and Systems Survey (HCAHPS).
The letter also noted that the ongoing consolidation in healthcare markets is increasing the prices of healthcare, and that POHs create additional competition in the hospital market and therefore motivate other hospitals to make improvements in their operations. POHs also give physicians an alternative to joining the very large health systems that are being created by the consolidation of markets. In addition, the letter included information from a report of a POH-focused observational study that was published in the British Medical Journal in September 2015, which was favorable to POHs.
Turning to the final rule filed by CMS on December 4, the agency finalized the proposed rule with no changes. The agency noted that, citing various studies, many commenters supported the proposed rule and numerous commenters opposed it. CMS mentioned that one of the supporting studies was the one referred to above that was published in the British Medical Journal 20 2015. Another supporting study was one published in 2016 by the American College of Surgeons. Commenters opposing the proposal cited a 2005 MedPAC report and a 2005 report from the Congressional Budget Office, as well as a 2017 blog that said POHs continue to cherry pick patients (according to data from Dobson | DaVanzo).
It should be noted that this final rule only concerns the interpretation of specific statutory exceptions relating to high Medicaid facilities. The POH-related efforts of the OrthoForum Advocacy Committee have concerned POHs generally. Our efforts with officials of the Department of Health and Human Services have focused on the broad, general authority of the Department under the Stark Law to create exceptions by regulation. We have argued that, under this authority, the Department could issue a regulation authorizing the expansion of POHs, notwithstanding the Stark statutory restrictions. This argument is based on the way the statute is drafted. The statute appears to state that exceptions created by regulation would control over the POH statutory restrictions.
This final rule is a step in the right direction.

POH Subcommittee
For more information on POH issues, or to join the OrthoForum Advocacy Committee POH Subcommittee, please contact Dr. Blake Curd at bcurd@oi.md.
Political Update
Obviously with the general election just being completed, there are a lot of developments since our last update. Joe Biden was elected president, with both Democrats and Republicans setting turnout records. Democrats retained a majority in the House, but just barely. As of this writing, the Republicans have a 50 to 48 majority in the Senate seat, with two Republican-held seats in Georgia to be settled in a January 5th run-off. In this update we refer to the top Republican on each Senate committee as the chairman, and the top Democrat as the ranking member, with the understanding that that could change in January.
Even as election returns are being finalized, the president-elect is assembling his roster of top advisers. Xavier Becerra, currently attorney general of California, and previously a long-term House member, will be secretary of Health and Human Services. Vivek Murthy will again serve as Surgeon General, a post he held in the Obama administration. Rochelle Wallensky, chief of infectious diseases at Mass General, will head the Centers for Disease Control. Anthony Fauci will remain director of the National Institute of Allergy and Infectious Diseases and will also serve as the president’s chief medical adviser on COVID-19.
As of this date, the president-elect has not announced HHS appointments below the secretary, so we do not know who will head the Center for Medicare and Medicaid Services, who will fill the crucial deputy and assistant secretary slots, etc.
Current conversations about Biden’s health care agenda are focusing almost entirely on response to the coronavirus. We know that Biden hopes to improve the Affordable Care Act, adding a public option via Medicare and expanding coverage to more low-income Americans. Biden has also promised to end “surprise billing,” increase antitrust enforcement to combat concentration in the healthcare industry, and lower the cost of prescription drugs to consumers.
Most of these initiatives would require cooperation by Congress. That cooperation is unlikely to materialize if Republicans maintain control of the Senate; it is by no means certain even if Democrats take control. If Democrats win both Georgia Senate seats, then the Senate is divided 50-50 – effectively a majority for the Democrats, as the vice-president holds the tie-breaking vote. However, a single Democratic defector on any given issue would enable the Republicans to muster 51 votes, and thereby thwart Democratic legislation on that issue. In this scenario, Joe Manchin (WV), the most moderate Democratic senator, would likely become the most popular man in Washington. It is possible that a small group of centrists from both parties, like Sen. Bill Cassidy (R-LA) and Mark Warner (D-VA), would bring considerable leverage to bear on legislative negotiations.

While the Senate saw little turnover, there are a few changes worth noting. Assuming Republicans retain their majority, Sen. Chuck Grassley (IA) rotates out of the Finance Committee chair, and is expected to be replaced by Sen. Mike Crapo (ID). Crapo is a conservative who demonstrated a knack for bipartisanship as chairman of the Senate Banking Committee.
The popular chairman of the Health, Education, Labor and Pensions Committee, Lamar Alexander (TN), is retiring; in line to replace him are Richard Burr (NC) or Rand Paul (KY). Burr, who has completed his six-year term as chair of the Intelligence Committee, would get the chair if Republicans chose strictly by seniority, but he has announced that he is not running for re-election, which may cause the Republican caucus to pass him by. While Burr has a record of bipartisanship, Paul is a wild card. His clashes with Fauci over the government’s response to the coronavirus received plenty of attention this year.
Democrats, unlike Republicans, don’t limit the terms of their ranking members. As of now, we don’t expect any changes among the Democratic ranking members relevant to OrthoForum.
Even after the Georgia Senate contests are decided, the Senate will welcome at least one new member. With Kamala Harris moving to the vice-president’s office, California governor Gavin Newsom will appoint a replacement. Dianne Feinstein, the oldest member of the Senate, recently stepped aside as ranking member of the Judiciary Committee, leading to rumors that she will step down and give Newsom a second seat to fill.
On the key House committee, Ways and Means, we expect no changes at the top. Richie Neal (MA-1) and Kevin Brady (TX-8) will remain chairman and ranking member, respectively.
We will continue to monitor the new administration for announcement of appointments and agenda items. We will also watch for leadership and committee membership changes in both the Senate and the House.



































































